Management of Hematuria with Proteinuria and Cellular Casts

Initial Diagnostic Workup

The presence of RBCs, cellular casts, and 3+ proteinuria strongly indicates glomerular disease requiring immediate nephrology referral and renal biopsy for definitive diagnosis and treatment, according to Praxis Medical Insights 1
Quantify proteinuria with a 24-hour urine collection or spot urine protein-to-creatinine ratio to determine exact protein excretion (3+ proteinuria likely exceeds 1g/day) 1, 2
Assess renal function with serum creatinine and estimated GFR 1
Evaluate for systemic diseases associated with glomerulonephritis through laboratory testing, including complete blood count 2, comprehensive metabolic panel 2, complement levels (C3, C4) 2, antinuclear antibody (ANA) 2, anti-double stranded DNA antibodies 2, anti-neutrophil cytoplasmic antibodies (ANCA) 1, hepatitis B and C serology 2, HIV testing 2, and serum and urine protein electrophoresis 2

Renal biopsy is indispensable as clinical, serological, or laboratory tests cannot accurately predict renal biopsy findings 3
The combination of hematuria (4 RBCs/hpf), cellular casts, and significant proteinuria (3+) strongly indicates the need for histological evaluation 1
Biopsy findings will determine specific diagnosis, prognosis, and guide treatment decisions 1

Lupus nephritis - especially with "full-house" immunofluorescence staining pattern 4
ANCA-associated vasculitis - particularly if areas of fibrinoid necrosis are present 4
IgA nephropathy - common cause of hematuria with proteinuria 1
Membranoproliferative glomerulonephritis 1
Crescentic glomerulonephritis 1

For lupus nephritis class III-IV, initial therapy options include mycophenolic acid (mycophenolate mofetil target dose: 3 g/day for 6 months) with glucocorticoids 4, and low-dose intravenous cyclophosphamide (total dose 3g over 3 months) with glucocorticoids 3
For patients with contraindications to high-dose corticosteroids, calcineurin inhibitors can be considered as first-line therapy 4
For significant proteinuria (>1 g/day), ACE inhibitor or ARB treatment should be initiated with uptitration depending on blood pressure, targeting <125/75 mmHg 2

Monitor response to therapy through proteinuria levels (target <0.5 g/24h) 2, renal function (serum creatinine) 1
If worsening occurs during the first 3 months of treatment, consider changing to alternative therapy or repeat kidney biopsy 4

Do not attribute hematuria solely to anticoagulation therapy when cellular casts and significant proteinuria are present 1
Do not delay nephrology referral, as early intervention may prevent disease progression 1
Normal renal ultrasound does not exclude glomerular disease 1